Gemictabine plus carboplatin in patients with advanced non-small cell lung cancer
Gemictabine plus carboplatin in patients with advanced non-small cell lung cancer
About this item
Full title
Author / Creator
Publisher
Middlesex: Springer Nature B.V
Journal title
Language
English
Formats
Publication information
Publisher
Middlesex: Springer Nature B.V
Subjects
More information
Scope and Contents
Contents
To evaluate the efficacy and safety of gemictabine combined with carboplatin for a chemotherapy regimen for patients with metastatic, recurrent, or locally advanced non-small cell lung cancer (NSCLC), 46 chemotherapy-naïve patients with histologically confirmed stage IIIB or IV NSCLC were treated with 1250 mg/m^sup 2^ of gemictabine on d 1 and 8, w...
Alternative Titles
Full title
Gemictabine plus carboplatin in patients with advanced non-small cell lung cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_875562852
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_875562852
Other Identifiers
ISSN
1357-0560
E-ISSN
1559-131X
DOI
10.1385/MO:22:4:359
